TeleTracking named 'Tech Titan of the Year' for second straight year

NewsGuard 100/100 Score
Sep 23 2011

TeleTracking Technologies, Inc. was named 'Tech Titan of the Year' for the second straight year at the Pittsburgh Technology Council's Tech 50 Awards, which annually honors the most successful and innovative companies in southwestern Pennsylvania's burgeoning technology sector.

The "Tech Titan" award recognizes the top performer among companies across multiple technology categories which generate $50 million and above annually.

"We built the company on the idea of sustainable and gainful employment growth, and that is what has made TeleTracking so successful," said Michael Zamagias, Chairman of the Board, accepting on behalf of TeleTracking.

SOURCE TeleTracking Technologies, Inc.

Posted in: Device / Technology News

Tags: ,

Comments (0)

Suggested Reading

New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses
New sustainable diagnostic approach offers precision cancer testing with minimal environmental impact
Mapping the Microbiome: Dr. Abidemi Junaid on the Groundbreaking Vagina Chip
Novel SARS-CoV-2 mutations found in floodwaters near homeless communities
Revolutionizing diabetes management with reliable blood glucose monitoring without finger pricking
Personality dictates binge-watching: Study reveals why we can't stop streaming
Advances and hurdles: The impact of AI on oncology care efficiency and mortality rates
New study reveals lifestyle factors boosting IVF success

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech